Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Article  Google Scholar 

Helicobacter infection and gastric neoplasia—PubMed. 2022. https://pubmed.ncbi.nlm.nih.gov/16362989/. Accessed 13 Jan 2022.

Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196–202.

Article  CAS  Google Scholar 

Bagheri V, Memar B, Momtazi AA, Sahebkar A, Gholamin M, Abbaszadegan MR. Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma. J Cell Physiol. 2018;233:2791–803.

Article  CAS  Google Scholar 

Becker C, Fantini MC, Wirtz S, Nikolaev A, Lehr HA, Galle PR, et al. IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle. 2005;4:217–20.

Article  CAS  Google Scholar 

Yao M, Brummer G, Acevedo D, Cheng N. Cytokine regulation of metastasis and tumorigenicity. Adv Cancer Res. 2016;132:265–367.

Article  CAS  Google Scholar 

Bronte-Tinkew DM, Terebiznik M, Franco A, Ang M, Ahn D, Mimuro H, et al. Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res. 2009;69:632–9.

Article  CAS  Google Scholar 

Jenkins BJ, Grail D, Nheu T, Najdovska M, Wang B, Waring P, et al. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nat Med. 2005;11:845–52.

Article  CAS  Google Scholar 

Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14:736–46.

Article  CAS  Google Scholar 

Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798–809.

Article  CAS  Google Scholar 

Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20:5–20.

Article  CAS  Google Scholar 

Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.

Article  CAS  Google Scholar 

Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4:199–227.

Article  CAS  Google Scholar 

Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang S-M. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Mol Cancer. 2014;13:35.

Article  CAS  Google Scholar 

Lin Y, Jian Z, Jin H, Wei X, Zou X, Guan R, et al. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway. Cell Death Dis. 2020;11:34.

Article  CAS  Google Scholar 

Chen E, Li E, Liu H, Zhou Y, Wen L, Wang J, et al. miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy. Int J Biol Sci. 2021;17:781–95.

Article  CAS  Google Scholar 

Zhang L, Du Y, Xu S, Jiang Y, Yuan C, Zhou L, et al. DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC. Cancer Lett. 2019;442:242.

Article  CAS  Google Scholar 

Ma S, Wei H, Wang C, Han J, Chen X, Li Y. MiR-26b-5p inhibits cell proliferation and EMT by targeting MYCBP in triple-negative breast cancer. Cell Mol Biol Lett. 2021;26:52.

Article  CAS  Google Scholar 

Li Y, Sun Z, Liu B, Shan Y, Zhao L, Jia L. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer. Cell Death Dis. 2017;8:e2892.

Article  CAS  Google Scholar 

Miyamoto K, Seki N, Matsushita R, Yonemori M, Yoshino H, Nakagawa M, et al. Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer. Br J Cancer. 2016;115:354–63.

Article  CAS  Google Scholar 

Kato M, Goto Y, Matsushita R, Kurozumi A, Fukumoto I, Nishikawa R, et al. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer. Int J Oncol. 2015;47:710.

Article  CAS  Google Scholar 

Zhou J, Ye J, Zhao X, Li A, Zhou J. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Toxicol Appl Pharmacol. 2008;230:33–40.

Article  CAS  Google Scholar 

Chandrashekar DS, Bashel B, Balasubramanya SA, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BV, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, NY). 2017;19:649.

Article  CAS  Google Scholar 

Lai SH, Zervoudakis G, Chou J, Gurney ME, Quesnelle KM. PDE4 subtypes in cancer. Oncogene. 2020;39:3791–802.

Article  Google Scholar 

Huang Z, Liu J, Yang J, Yan Y, Yang C, He X, et al. PDE4B induces epithelial-to-mesenchymal transition in bladder cancer cells and is transcriptionally suppressed by CBX7. Front Cell Dev Biol. 2021;9:783050.

Article  Google Scholar 

Martinez-Fabregas J, Wang L, Pohler E, Cozzani A, Wilmes S, Kazemian M, et al. CDK8 fine-tunes IL-6 transcriptional activities by limiting STAT3 resident time at the gene loci. Cell Rep. 2020;33:108545.

Article  CAS  Google Scholar 

Kang K, Bachu M, Park SH, Kang K, Bae S, Park-Min K-H, et al. IFN-γ selectively suppresses a subset of TLR4-activated genes and enhancers to potentiate macrophage activation. Nat Commun. 2019;10:3320.

Article  Google Scholar 

Ding X, Sharko AC, McDermott MSJ, Schools GP, Chumanevich A, Ji H, et al. Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo. Proc Natl Acad Sci U S A. 2022;119:e2201073119.

Article  CAS  Google Scholar 

Parri E, Kuusanmäki H, van Adrichem AJ, Kaustio M, Wennerberg K. Identification of novel regulators of STAT3 activity. PLoS ONE. 2020;15:e0230819.

Article  CAS  Google Scholar 

Wang H, Luo J, He Q, Yao D, Wu J, Loor JJ. miR-26b promoter analysis reveals regulatory mechanisms by lipid-related transcription factors in goat mammary epithelial cells. J Dairy Sci. 2017;100:5837–49.

Article  CAS  Google Scholar 

Qian S, Golubnitschaja O, Zhan X. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA J. 2019;10:365–81.

Article  Google Scholar 

Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol. 2006;208:233–48.

Article  CAS  Google Scholar 

Li G, Wang Z, Ye J, Zhang X, Wu H, Peng J, et al. Uncontrolled inflammation induced by AEG-1 promotes gastric cancer and poor prognosis. Cancer Res. 2014;74:5541–52.

Article  CAS  Google Scholar 

Zhang X, Soutto M, Chen Z, Bhat N, Zhu S, Eissmann MF, et al. Induction of fibroblast growth factor receptor 4 by helicobacter pylori via signal transducer and activator of transcription 3 With a feedforward activation loop involving steroid receptor coactivator signaling in gastric cancer. Gastroenterology. 2022;163:620-636.e9.

Article  CAS  Google Scholar 

Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117:60–9.

Article  CAS  Google Scholar 

Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.

Article  CAS  Google Scholar 

Jeffries J, Zhou W, Hsu AY, Deng Q. miRNA-223 at the crossroads of inflammation and cancer. Cancer Lett. 2019;451:136–41.

Article  CAS  Google Scholar 

Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, et al. The role of miRNA in inflammation and autoimmunity. Autoimmun Rev. 2013;12:1160–5.

Article  CAS  Google Scholar 

Li Y, Peng C, Fang C, Huang K. Upregulation of nuclear-enriched abundant transcript 1 confers oxaliplatin resistance to gastric cancer. Cell Biol Int. 2020;44:446–55.

Article  CAS  Google Scholar 

Deng M, Zhang R, He Z, Qiu Q, Lu X, Yin J, et al. TET-mediated sequestration of miR-26 drives EZH2 expression and gastric carcinogenesis. Cancer Res. 2017;77:6069–82.

Article  CAS  Google Scholar 

Zhao B, Zhang J, Chen X, Xu H, Huang B. Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer. Arch Med Sci. 2019;15:498–503.

Article  CAS  Google Scholar 

Azam MA, Tripuraneni NS. Selective phosphodiesterase 4B inhibitors: a review. Sci Pharm. 2014;82:453–81.

Article  CAS  Google Scholar 

Wu D, Zhang Z, Chen X, Yan Y, Liu X. Angel or Devil ?—CDK8 as the new drug target. Eur J Med Chem. 2021;213: 113043.

Article  CAS  Google Scholar 

Kim M-Y, Han SI, Lim S-C. Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma. Int J Oncol. 2011;38:1375–83.

CAS 

留言 (0)

沒有登入
gif